Profile data is unavailable for this security.
About the company
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
- Revenue in USD (TTM)12.74m
- Net income in USD-2.98m
- Incorporated2003
- Employees28.00
- LocationBioLine RX LtdModi'in Technology Park2 HaMa'ayan StreetMODIIN 7177871IsraelISR
- Phone+972 86429100
- Fax+972 86429101
- Websitehttps://www.biolinerx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Soligenix Inc | 0.00 | -11.46m | 11.50m | 14.00 | -- | 1.48 | -- | -- | -3.66 | -3.66 | 0.00 | 0.7705 | 0.00 | -- | -- | 0.00 | -105.25 | -73.79 | -165.82 | -151.46 | -- | 22.19 | -- | -1,147.93 | -- | -- | 0.00 | -- | -85.78 | -51.89 | -34.62 | -- | -- | -- |
| Longeveron Inc | 1.44m | -21.34m | 11.91m | 25.00 | -- | 1.18 | -- | 8.29 | -1.34 | -1.34 | 0.0909 | 0.4732 | 0.0632 | -- | 6.65 | 57,480.00 | -93.88 | -70.26 | -114.04 | -83.92 | 74.88 | 44.57 | -1,485.11 | -683.81 | -- | -- | 0.00 | -- | 237.38 | -15.76 | -10.86 | -- | 51.32 | -- |
| Check Cap Ltd | 0.00 | -13.62m | 12.39m | 85.00 | -- | 2.64 | -- | -- | -2.33 | -2.33 | 0.00 | 0.6432 | 0.00 | -- | -- | -- | -114.23 | -61.64 | -130.02 | -67.99 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -43.15 | -- | -- | -- |
| BioLine RX Ltd - ADR | 12.74m | -2.98m | 12.50m | 28.00 | -- | 0.626 | -- | 0.9819 | -1.30 | -1.30 | 3.59 | 4.49 | 0.2752 | 2.19 | 7.05 | 454,821.40 | -6.43 | -48.18 | -11.04 | -63.37 | 50.69 | -- | -23.38 | -450.09 | 1.93 | -2.59 | 0.3681 | -- | 502.92 | -- | 84.79 | -- | -5.85 | -- |
| GT Biopharma Inc | 0.00 | -34.45m | 12.52m | 1.00 | -- | 2.07 | -- | -- | -3.93 | -3.93 | 0.00 | 0.2266 | 0.00 | -- | -- | 0.00 | -459.62 | -172.68 | -1,377.41 | -460.87 | -- | -- | -- | -- | -- | -3,105.50 | 0.00 | -- | -- | -- | -161.73 | -- | -- | -- |
| Hookipa Pharma Inc | 9.35m | -73.31m | 12.82m | 82.00 | -- | 0.3684 | -- | 1.37 | -5.85 | -5.85 | 0.7457 | 2.82 | 0.0903 | -- | 1.74 | 114,036.60 | -70.79 | -40.82 | -91.08 | -50.56 | -- | -- | -784.01 | -266.20 | -- | -- | 0.00 | -- | 118.32 | 29.77 | 46.67 | -- | -37.28 | -- |
| Curanex Pharmaceuticals Inc | 0.00 | -1.30m | 12.97m | -- | -- | 0.9074 | -- | -- | -0.0497 | -0.0497 | 0.00 | 0.5043 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -142.76 | 0.00 | -- | -- | -- | -1,782.87 | -- | -- | -- |
| Kairos Pharma Ltd | 0.00 | -5.06m | 13.00m | 1.00 | -- | 1.70 | -- | -- | -0.3045 | -0.3045 | 0.00 | 0.3681 | 0.00 | -- | -- | 0.00 | -77.46 | -- | -92.07 | -- | -- | -- | -- | -- | -- | -94.05 | 0.00 | -- | -- | -- | -43.65 | -- | -- | -- |
| NewcelX AG | 0.00 | -6.21m | 13.04m | 1.00 | -- | 0.4213 | -- | -- | -20.39 | -20.39 | 0.00 | 6.94 | 0.00 | -- | -- | 0.00 | -78.31 | -232.34 | -- | -- | -- | -- | -- | -- | -- | -53.01 | 0.00 | -- | -- | -- | 66.67 | -- | -- | -- |
| Traws Pharma Inc | 2.85m | 93.35m | 13.18m | 7.00 | 0.0584 | 2.59 | -- | 4.63 | 28.24 | 28.24 | 0.4566 | 0.6373 | 0.2662 | -- | 1.38 | 406,571.40 | -124.51 | -151.85 | -517.46 | -207.35 | -- | -- | -467.64 | -21,652.42 | -- | -- | 0.00 | -- | 0.00 | -36.47 | -188.55 | -- | -- | -- |
| BioCardia Inc | 0.00 | -8.54m | 13.48m | 17.00 | -- | 5.13 | -- | -- | -1.73 | -1.73 | 0.00 | 0.2476 | 0.00 | -- | -- | 0.00 | -137.58 | -102.48 | -272.63 | -150.23 | -- | -- | -- | -1,938.01 | -- | -- | 0.00 | -- | -87.84 | -39.41 | 31.33 | -- | -47.18 | -- |
| Curis Inc | 11.65m | -36.56m | 13.60m | 33.00 | -- | -- | -- | 1.17 | -3.68 | -3.68 | 1.05 | -1.15 | 0.3323 | -- | 3.75 | 353,030.30 | -104.28 | -37.70 | -259.56 | -42.63 | 99.47 | 96.89 | -313.79 | -423.79 | -- | -- | -- | -- | 8.83 | 1.75 | 8.49 | -- | -- | -- |
| Anebulo Pharmaceuticals Inc | 0.00 | -7.98m | 13.62m | 2.00 | -- | 1.73 | -- | -- | -0.1942 | -0.1942 | 0.00 | 0.1932 | 0.00 | -- | -- | 0.00 | -63.16 | -108.15 | -69.69 | -112.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3.45 | -- | -- | -- |
| Bioatla Inc | 0.00 | -64.71m | 13.74m | 61.00 | -- | -- | -- | -- | -1.15 | -1.15 | 0.00 | -0.5313 | 0.00 | -- | -- | 0.00 | -165.61 | -49.22 | -317.99 | -57.35 | -- | -- | -- | -3,690.17 | -- | -- | -- | -- | -- | 16.17 | 43.48 | -- | -- | -- |
Data as of Mar 03 2026. Currency figures normalised to BioLine RX Ltd's reporting currency: US Dollar USD
1.10%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Citadel Securities LLCas of 31 Dec 2025 | 36.65k | 0.84% |
| RhumbLine Advisers LPas of 31 Dec 2025 | 3.35k | 0.08% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 2025 | 2.04k | 0.05% |
| UBS Securities LLCas of 31 Dec 2025 | 1.95k | 0.05% |
| Wells Fargo Advisors Financial Network LLCas of 31 Dec 2025 | 1.75k | 0.04% |
| BNP Paribas Financial Marketsas of 31 Dec 2025 | 1.50k | 0.03% |
| The Nemes Rush Group LLCas of 31 Dec 2025 | 250.00 | 0.01% |
| NewEdge Advisors LLCas of 31 Dec 2025 | 107.00 | 0.00% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 100.00 | 0.00% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2025 | 26.00 | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
